Edit
Cardeas Pharma Corp
http://cardeaspharma.com/Last activity: 23.12.2013
Active - Reference to cardeaspharma.com
Early phase development of inhaled antibiotics to treat serious, hospital-acquired respiratory infections with highly antibiotic-resistant organisms. By combining novel formulations of proven antibiotics with cutting edge drug delivery technology, Cardeas is addressing significant unmet medical needs in the critical-care setting.
Employees: 11-50
Total raised: $34M
Founded date: 2010
Investors 1
| Date | Name | Website |
| - | Delphi Ven... | delphivent... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 22.05.2013 | Series B | $34M | - |
Mentions in press and media 3
| Date | Title | Description |
| 23.12.2013 | Deals of the Year: The top 28 venture capital investments we tracked in 2013 | Venture capital investing in Washington state started out with a whimper in 2013, but it is ending with a bang. After the slow start, as evidenced by the chart above from CB Insights in which just $100 million was invested in the first quar... |
| 23.05.2013 | Cardeas Pharma Completes $34M Series B Financing | Cardeas Pharma Corporation, a Seattle, WA-based biopharmaceutical company focused on the development of innovative therapies for the treatment of multi-drug resistant (MDR) bacterial infections, completed a $34m Series B financing. The roun... |
| 22.05.2013 | Bruce Montgomery biotech startup Cardeas Pharma raises $34 million | Bruce Montgomery It has been a good week for the Seattle life sciences community. On Monday, Seattle genomics tool maker NanoString Technologies filed for an initial public offering that could raise up to $86 million. Now, comes word that C... |